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T o promote the exchange of information about ideas and techniques, the Third International Workshop on Langerhans Cells was organized to include rela-tively long periods of time for discussion. Although we had originally intended to publish an edited ver-
sion of that discussion, it became obvious that much of the material 
was covered by each manuscript. As a compromise, the pages that 
follow provide a brief review of the discussion, focusing on impor-
tant issues, problems, and questions that emerged. Our goal is to 
rovide readers interested in the biological and immunological 
;spects of Langerhans cells (LC) with an overview that allows them 
to place the entire W.orkshop into p~rspective. We. have organized 
this review around SIX noteworthy Issues concernll1g Langerhans 
cells, including 1) their "true" identity, 2) migratory properties, 3) 
cytokine profiles, 4) Fc receptors, 5) interactions with biologic anti-
gens, an~ 6) mechanisms by which UVB radiation induces immuno-
suppressIOn. 
The workshop was set into lively motion by Dr. RudolfL. Baer, a 
distinguished colleague, who has served as scientific investigator as 
well as a facilitator of the work of others during the two decade-
long explosion of knowledge about LC. 
WHAT IS THE "TRUE" IDENTITY OF 
LANGERHANS CELLS? 
As neW data about LC have accumulated, investigators have become 
less convinced that their defining features are either uniform or 
stable. A decade ago, LC were characterized as resident epidermal 
cells that exhibit a dendritic morphology in situ, express cell-surface 
MHC class II antigens, CD1 and ATPase, and contain a characteris-
tic microstructure, the Birbeck granule. Although these features did 
describe the overwhelming majority of LC in normal epidermis, 
they and other more recently reported features fall short when em-
ployed to address contemporary questions, such as ontogeny, migra-
tory properties, and responses to exogenous stimuli. In fact, as will 
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be demonstrated in the following, it is now certain that LC, as a class 
of dendritic cells (DC), are not uniform in either phenotype or 
function. In addition, mechanisms for the expression of these dif-
ferent phenotypes is not certain, giving rise to two non-exclusive 
possibilities, that DC divide into several permanent and distinct 
lineages and/or that they are a single population, the members of 
which acquire unique states of activation, depending on their loca-
tion and/or their recent experience. This interaction between phe-
notype and function figured prominently in the course of the work-
shop. 
The issues of subsets and lineage do not begin with LC, rather 
they begin with the special relationship between LC and DC, in-
cluding both their similarities and their differences. First, several 
areas of agreement were reached concerning the current under-
standing of DC. In terms of phenotype and function, it was agreed 
that DC exhibit 1) a veiled or dendritic morphology, 2) modest 
phagocytic capacity, and 3) potent capacity to activate naive T cells. 
~oreover, investigators agreed with a general concept of DC life 
history; they 1) are derived from precursors in bone marrow, 2) 
distribute via the blood to selected tissues, 3) home to their respec-
tive tissues (for LC this might be immediately or after an unknown 
period of retention in the dermis), 4) leave that tissue and migrate 
toward draining lymph nodes following an activation step asso-
ciated with exposure to an antigen (Ag), 5) mature into more "po-
tent" DC, and 6) stimulate selected but immunologically naive T 
cells upon entry into lymph nodes. 
The next relevant question concerned characterization of DC 
subsets. In fact, at least five distinct subsets were discussed in the 
workshop: 1) LC in epithelial tissues, 2) DC in peripheral blood or 
lymph, 3) interdigitating DC in T -cell - dependent areas of lymph-
oid tissues, 4) follicular DC in B-cell-dependent areas, and 5) der-
mal dendrocytes or perivascular DC in dermis. 
P~r~pheral blood DC are identified routinely by their capacity to 
exhibit by phase-contrast microscopy a "veiled" or "dendritic" mor-
pholo~y . DC: have also been identified by their cell-surface pheno-
type, lI1cludll1g the constitutive expression of large amounts of 
HLA-DP, -DQ, and -DR, the high-affinity IL-2 receptor, and low 
levels of CD4 and CD40. 
. Returning to LC as a class, data presented in the workshop clearly 
Illustrated that LC are not stable; rather, they exhibit considerable 
dynamism, migrating into and out of epidermis, and modifying 
?oth their phenotype and critical aspects of their function, depend-
ll1g on their location, state of maturation, and the stimulatory fac-
tors provided. One attractive and frequently discussed idea has been 
that resident LC in epidermis are "immature" and that they "ma-
ture" in tissue culture as they acquire characteristic features of classic 
DC [1,2]. These observations have given rise to the hypothesis that 
similar maturational steps occur as LC leave the epidermis. 
On the other hand, dermal dendrocytes may represent " imma-
ture LC." These cells have been characterized by their preferential 
localization around blood vessels, and by their expression of HLA-
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DR, CD1a, CD1b, CD1c, and CD11c (Cooper, Furue*). By con-
trast, LC in epidermis express HLA-DR, CD1a, faint CD1c, 
FceRII/CD23, and FcyRII/CD32, but not CD1b or CD40. Be-
cause of potential effects of procurement techniques, including 
trypsinization, the question whether LC express adhesion mole-
cul es such as ICAM-1, LFA-3, CD11a, CD11b, CD11c, or CD18 
in situ has not been answered, whereas cultured human LC certainly 
express some of these molecules (Teunissen). 
Ultimately, a discussion ofLC identity leads to critical questions 
concerning relationships among the different DC subsets. At which 
points do the lineages of monocytes, DC, and LC diverge? Do DC 
subsets represent cells of recently divergent lineage or do they sim-
ply represent the same cell with phenotypes that reflect differences 
in location? Are dermal dendrocytes precursors of epidermal LC, 
and, if so, do they change their phenotype before or after gaining 
entry into the epidermis? Is the epidermal microenvironment (e.g., 
cytokines and adhesion molecules) responsible for this change? 
With regard to LC precursors, it was reported that hapten painting 
causes the appearance in dermis and epidermis of "immature LC" 
that were distinct from dermal dendrocytes and from epidermal LC 
(Kolde). 
WHAT SIGNALS FACILITATE THE MIGRATION OF 
LANGERHANS CELLS? 
A large body of evidence now documents the ability ofLC to move. 
This evidence began to accumulate more than a decade ago with the 
observation that LC are derived from bone marrow precursors [3], 
implying that they must subsequently move to skin (presumably to 
dermis via the blood stream, and then to epidermis by chemotaxis). 
More recently, studies with corneas have demonstrated LC to ex-
hibit rapid lateral chemotactic responses to IL-1 (Niederkorn). Fi-
nally, hapten painting can induce LC to depart from epidermis and 
to enter draining lymphatics, eventually reaching regional lymph 
nodes within a short period of time [4]. Studies presented in the 
workshop addressed several aspects of these processes. First, LC 
precursors from peripheral blood were observed to migrate into 
human skin grafts that had been reconstituted in vivo in immuno-
deficient mice (Rowden, Demarchez). Secondly, it was reported 
that LC procured from trypsin-disaggregated mouse epidermis re-
tained their capacity to migrate back into epidermis (Cruz, Saitoh). 
Finally, after LC gain entry to the epidermis, residence may be 
facilitated by their marked adhesiveness to keratinocytes (Taka-
shima). 
Two laboratories reported elegant in vivo methods for monitor-
ing LC movement by cannulating lymph vessels that drain sites of 
skin painting. These data indicate that painting with allergic or 
irritant contact sensitizers, or with chemical carcinogens, produces 
rapid migration of LC into afferent lymphatics (Brand, Dandie). 
These observations led to a lively discussion concerning the ulti-
mate fate of these cells, once they gain entry into a regional lymph 
node. How long do they reside there? Do they survive and return to 
the epidermis? From the discussion, the consensus was that the 
majority of emigrating LC are retained in the first draining lymph 
node that is reached. DC (and perhaps LC) may serve as targets of 
natural killer cells (or of cytotoxic T cells), suggesting that LC are 
destroyed after they have stimulated T cells. On the other hand, as 
many as 1 % of cells in the thoracic duct are DC, thereby suggesting 
the. opposing view that a significant number of LC survive and 
reCirculate. 
Important questions were raised concerning the signals that ordi-
narily produce LC movement. IL-1 is clearly one candidate, particu-
larly with respect to movement into the epidermis (Niederkorn) . 
With respect to movement out of the epidermis, a role for tumor 
necrosis factor-a (TNFa) was proposed; intradermal injection of 
TNFa causes a significant increase in the number of DC found 
within draining lymph nodes (Kimber). On the other hand, this 
'References to abstracts and papers from the workshop arc made by citing 
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conflicted with observations suggesting that TNFa may immobi-
lize LC within the epidermis [5] . 
Issues ofLC adhesion within the extracellular matrix also figured 
prominently in the discussion. With respect to the specific adhesion 
molecules that might promote migration, it was reported that LC 
have the capacity to bind to extracellular matrix proteins via P1 
integrins (Staquet). Much remains to be clarified, however, includ-
ing the question of whether this adhesion through receptors pro-
motes or retards cell movement. 
WHAT ROLES ARE PLAYED BY CYTOKINES IN 
LC FUNCTION? 
Cytokines are now recognized to play important roles in the initia-
tion, amplification, and termination of immunologic reactions. The 
seminal observation that keratinocytes elaborate a cytokine indistin-
guishable from IL-1 [6] was only the beginning of presently contin-
uing discoveries of a large catalog of proteins, both cytokines and 
growth factors, produced by these cells. Some of these factors regu-
late LC functions, including their migration, expression of surface 
molecules, and survival. Aside from the early observation that IL-1 
activity detected in culture supernatants was secreted by both kerati-
nocytes and LC [7], little has been reported concerning the profile of 
cytokines produced by LC alone. 
New information is now on the horizon. Three laboratories re-
ported mouse LC to express mRNA for IL-1P, MIP-1a, and IL-6, as 
detected by reverse transcriptase followed by polymerase chain reac-
tion (RT-PCR) (Enk, Schreiber, Matsue). These important reports 
led to questions concerning the care that must be taken when em-
ploying a sensitive detection technique such as PCR, and when 
interpreting results that are obtained. Minor contaminating popula-
tions may be inadvertent sources of detected mRN A. In overcoming 
this problem, it was recognized that the use of LC lines and clones 
derived from epidermis, although ideal in terms of cell purity, 
would have the disadvantage of not reflecting in situ levels of 
mRNA. Ultimately, rapidly procured and highly enriched popula-
tions of LC will be required. 
Unfortunately, even rapid techniques of LC isolation may have 
substantial effects on mRNA levels; within 15 min as much as a 
hundredfold increase in message for IL-6 has been observed in epi-
dermis as compared with "baseline" levels. Compounding this 
problem, it was also argued that mRN A expression may be "upregu-
lated" by artifactual stimuli. The first example concerned the 
highly relevant question of whether experimental animals are path-
ogen-free. The second example concerned whether the reported 
"constitutive" expression of IL-1P, for instance, has been induced 
by trace amounts oflipopolysaccharide that may contaminate buffer 
solutions or culture media. Thus, as assays for mRNA and for pro-
teins become more sensitive, these questions will recur repeatedly. 
The obvious conclusion from the workshop was that at present it is 
difficult to ascertain that " resting" LC in situ express the same 
cytokine mRNA profiles as revealed by in vitro analyses. 
Taken together, these studies led investigators to recognize that 
the paracrine cytokine network within epidermis should be studied 
along two directions: keratinocyte-derived cytokines that regulate 
the activities ofLC and LC-derived cytokines that regulate keratino-
cytes. Finally, the ultimate issue concerns how exogenous stimuli 
may regulate cytokine production by LC. For example, it was re-
ported that hapten painting modulates cytokine mRNA profiles in 
epidermis, of which LC are responsible for upregulated IL-lP 
(Enk). 
WHAT IS THE FUNCTION OF FC RECEPTORS 
EXPRESSED ON LC? 
Important new knowledge has been forthcoming concerning the 
presence and function of Fc receptors on LC. This set of issues dates 
back to the observation that human LC are capable of binding Fc 
fragment of IgG [8] . In this respect, three distinct receptor mole-
cules have now been identified in human leukocytes, FcyRI/CD64, 
FcyRII/CD32, and FcyRIII/CD16. It has been peviously shown 
that FcyRII is responsible for IgG binding to LC 19]. A novel obser-
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tion reported in the workshop was that LC express Fcyll not only 
va the cell surface, but also secrete this molecule into culture media (d la Salle). These investigators have cloned two forms of cDNA 
f em human LC: one encoding Fcyll that contains the transmem-:0 ne domain (membrane-associated form), the other external to th~s domain (soluble form). Moreover, mRNA expression of these 
twO forms of Fcyll appea~s to be regul~ted ?y ,!,N~a. Many ques-
. s were raised concermng the phYSiologic slgmficance of these ~~dings. Does a me~bran~ form of Fcyll mediate binding and 
. t rnalization of antigens via IgG? Does a soluble form serve as an In e . . d . 
. hibitor in this function? How are Fcyll expression an secretIOn In . . ? 
e ulated in LC m SitU. 
r ~uman LC also possess IgE-binding capacity, and early studies 
d monstrated LC in atopic dermatitis patients to bind IgE [10]. On ~ other hand, the specificity of this phenomenon for atopic der-~:titis cannot be assured, as it ha.s ?ee~ show~ that LC in other 
d' eases with elevated IgE also exhibit thiS function [11]. Two IgE-b~s ding structures were previously found on human LC; FceRII/ d~23 (low-affinity receptor) and eBP (so-called IgE-binding pro-
. ) [12]. In the workshop, two laboratories demonstrated that ~I~an LC also express the high-affinity IgE receptor, FceRI (or an 
F ueRI analogue with different molecular configuration), by using R~-PCR and by specific mon?c1on.al antibodies (Bieb~r, Ri~ger). 
These findings stimulated diSCUSSiOn about the functional slgmfi-
nce of IgE receptors on LC, and new evidence is beginning to ~:nerge. In fact, IgE-me?!ated ~g presentation has been reported in 
LC from atopic dermatitis patients [13] . It was also suggested that 
cell-surface IgE may. serve as a r~cep~or .for certain Ag, thereby 
mediating high-affimty and selective bmdmg of Ag, ~n.d(or.effec-
. ve internalization of these molecules. Another pOSSIbility IS that 
tl osslinked IgE may stimulate the secretion of cytokines by LC. ~dditional discussion ~oncerned how the expression of Ig~ recel?-
tors is regulated. First, It would appear th~t not all LC, even m atopic 
dermatitis, express FceRI, and LC dUring culture appear to lose 
FceR!. The finding that FceRII expression by LC can be upregu-
I ted by IL-4 and IFNy [12] suggests that cytokines secreted by 
:pidermal cells may modulate IgE receptor turnover in LC. 
BY WHAT MECHANISMS DO LC INTERACT WITH 
BIOLOGIC ANTIGENS? 
One property of LC 'retained central focus throu.ghout the ~ork­
shop: their capacity to present A~ to T cell~ With extraordm.ary 
efficiency. These Ag include ch~mlcally reac~lve haptens, protems, 
and allogeneic cellular det:rmma~ts. A~ might be expected, the 
discussion centered pnmanly on mfectlous agents, haptens and 
rumors. Considerable discussion was prompted by the report that 
mouse LC are capable of processing and presenting tumor antigens 
to CD4+ T cells and that this activity is highly regulated by cyto-
kines [e.g., IL-la, granulocyte macrophage/colony-stimulating 
factor (GM-CSF) , and TNFa] th~t are secreted by keratinocyt~s 
(Grabbe). This gave rise .to questions about the. role LC play . 111 
immune surveillance aga111st tumors. Can one 1l1duce protective 
immunity against tumors by the adoptive transfer of such CD4+ T 
cells or through immunization with tumor-pulsed LC? It was re-
marked that immunization of naive animals with tumor-pulsed LC 
causes a delay of growth of inoculated tumor cells [14]; this proto-
col, however, was less effective in animals that have already carned 
rumors. It was noted that spleen DC pulsed with tumor cells are also 
capable of producing protective ~m~~nity (Knight). .. 
Clinical findings that LC denSity IS 111creased or decreased 111 skm 
lesions of American cutaneous leishmaniasis, depending upon the 
immunologic responses to the parasites (Caceres-Dittmar), raised 
several important questions. Does this mean that LC are targets of 
parasite infection or that they are responsible for presenting parasite 
Ag to T cells? In fact, infection and replication of Leishmania major 
within LC has been reported [15]. Which T-cell subset (Th 1 or 
Th2) is primarily activated? It was mentioned that PCR analyses of 
cytokine mRNA present in skin lesions failed to clarify this issue, 
--- , 
DISCUSSION OVERVIEW 3S 
revealing cytokine profiles of ThO type instead. Does ultraviolet B 
(UVB) radiation modulate parasite infection and/or subsequent im-
mune reaction? Obviously, this question is difficult to address clini-
cally, because sun-exposed areas of the body are also the sites fre-
quently bitten by the leishmania vector, the sandfly. On the other 
hand, this question can be addressed in murine models of Leishman-
iasis (Sanchez). 
The role of LC in human immunodeficiency vims (HIV) infec-
tions was given much attention in the workshop. Beginning with 
the seminal observation of Tschachler [16], that HIV are found in 
LC, the question that reverberated was whether LC are a relevant 
target for HIV, taking into account the fact that perhaps only a small 
proportion of LC in skin of HIV -1 + patients are infected with the 
virus. In the course of the discussion, three major issues were consid-
ered. 1) Can LC be infected with HIV? 2) If so, does CD4 molecule 
on LC serve as a receptor for HIV entry? 3) Do HIV replicate in LC 
to be transmitted to other leukocytes? Studies using in vitro infec-
tion systems did demonstrate that human LC, but not other epider-
mal cells, can be infected by HIV-l (Berger, Dusserre). Moreover, 
viral replication and transmission to lymphocytes were observed in 
these systems, suggesting that LC serve not only as targets for HIV-
1, but also as viral reservoirs and vectors for transmission, as has been 
demonstrated for peripheral blood DC (Langhoff) . 
BY WHAT MECHANISM(S) DOES UVB RADIATION 
INDUCE IMMUNOSUPPRESSION? 
UVB radiation is known to downregulate T cell- mediated imnlU-
nity in skin. Hapten application through UVB-irradiated skin re-
sults in the failure to immunize, and animals so treated can no longer 
be sensitized with the same hapten at a later date, even through 
normal skin [17]. Postulated mechanisms for this immunosuppres-
sive effect have received considerable attention. The simplest expla-
nation is that UVB radiation kills LC, and sensitization is not 
achieved because they are no longer available in epidermis. In fact, it 
was reported that in vitro exposure of mouse LC to fluences ofUVB 
that ordinarily inhibit APC activity cause LC death 48-72 h after 
UVB irradiation (Tang). This observation prompted the following 
questions. How can the tolerance be induced without antigen-pre-
senting cells (APC)? Do LC retain some aspects of antigen-present-
ing capacity in the interval before cell death? If so, does UVB cause a 
deficiency in cytokine production or a deficiency in co-stimulatory 
molecules on LC, that in turn leads to clonal anergy of T cells 
(Jenkins)? Does UVB cause influx of alternative APC that subse-
quently are responsible for immunosuppression? 
A second series of questions concerned the chromophores that are 
responsible for UYE-induced immunosuppression. Is DNA the sole 
target? What are the mediators responsible for modulation of APC 
function of LC? In fact, urocanic acid (UCA) in stratum corneum 
has been postulated to serve as a chromophore through photo iso-
merization of naturally occurring trans-UCA into cis-UCA. Cis-
UCA, in turn, has been reported to induce suppression in a variety of 
experimental circumstances, including through its topical applica-
tion [18]. Topical application of cis-UCA was reported at the work-
shop to produce morphologic changes and emigration of LC (Kuri-
moto, Norval). 
Finally, TNFa was discussed at length as a candidate molecule 
responsible for UVB-induced immune dysfunction. UVB radiation 
does induce increased secretion of TN Fa by keratinocytes [19] and 
TNFa does exert immunosuppressive effects in skin [20]. One uni-
fying proposal was that cis-UCA might serve as the chromophore to 
induce TNFa elaboration, which, in turn, would be responsible for 
the actual immunosuppression. This proposal was supported by the 
observation that anti-TN Fa antibodies reversed the immunosup-
pressive effects induced either by UVB radiation or by cis-UCA 
(Kurimoto). This raised the unanswered question whether cis-UCA 
has the capacity to upregulate TNFa secretion by keratinocytes. 
Ultimately, it is likely that UVB produces multiple effects in skin, 
and it is too early to be confident that a single mechanism, albeit 
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through DNA, UCA, or some as yet unidentified substance, pre-
dominates. 
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